Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

Summit
Favicon Fierce Biotech

AstraZeneca scales Summit’s PD-1xVEGF combos with $2B investment

AstraZeneca is investing $2 billion in Summit to accelerate the development of PD-1xVEGF bispecific ivonescimab in combination with ADCs.
Nick Paul Taylor Sep 29, 2026 3:07am
Heidi Overton at HELP committee nomination hearing
Favicon Fierce Biotech

Overton backs vaccines, mifepristone in confirmation hearing

Sep 24, 2026 2:32pm
Genentech

Roche reports positive confirmatory trial readout for Lunsumio

Sep 17, 2026 11:25am
Human kidney anatomy

Vera’s strong ph. 3 Trutakna data intensify IgAN rivalry

Sep 16, 2026 2:50pm
Cellares founders

Cellares, GenomeFrontier to evaluate CAR-T therapy production

Sep 16, 2026 2:02pm
Daniel ODay
Favicon Fierce Biotech

CEO O’Day tells Fierce how Gilead reached ‘critical mass’

Sep 16, 2026 8:00am